Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3244
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01786265 | Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer | ||
| NCT00038675 | Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate | ||
| NCT04789681 | Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial | ||
| NCT01294657 | Obesity: Cancer Risk Among African Americans | ||
| NCT00618553 | Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting | ||
| NCT04106245 | Effect of EHealth Coaching Program on Patient Reported Outcomes of Men With Prostate Cancer | ||
| NCT06345495 | High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly | ||
| NCT00972101 | Infusion of Expanded Cord Blood T Cells | ||
| NCT00498719 | Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer | ||
| NCT00113334 | Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer | ||
| NCT05554133 | Precision Optical Guidance for Oral Biopsy | ||
| NCT05026736 | Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study | ||
| NCT04765111 | Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma | ||
| NCT01262664 | A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity | ||
| NCT01187199 | Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer | ||
| NCT05055063 | A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma | ||
| NCT00505492 | Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy | ||
| NCT03259230 | Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis | ||
| NCT01946165 | Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide | ||
| NCT01469247 | Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) | ||
| NCT00491075 | Pemetrexed Plus Gemcitabine in Renal Cell Cancer | ||
| NCT02911064 | Expectations Regarding Mobility and Self-Care | ||
| NCT05961709 | The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer | ||
| NCT00418899 | Gliogene: Brain Tumor Linkage Study | ||
| NCT04723095 | Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix | ||
| NCT00677430 | Quantitative Analysis of Outcomes in Breast Reconstruction | ||
| NCT00851032 | Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol | ||
| NCT00038207 | Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies | ||
| NCT02754544 | Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors | ||
| NCT00003075 | Fenretinide in Treating Patients With Cervical Neoplasia | ||
| NCT01409200 | Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis | ||
| NCT00831792 | TKI258 in Castrate Resistant Prostate Cancer | ||
| NCT00903734 | An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status | ||
| NCT03225664 | Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced | ||
| NCT04216472 | Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations | ||
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | ||
| NCT03162627 | Selumetinib and Olaparib in Solid Tumors | ||
| NCT01750983 | Ipilimumab and Lenalidomide in Advanced Cancer | ||
| NCT02663583 | Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell | ||
| NCT01893372 | Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS) | ||
| NCT00394134 | Targeted Intervention for Melanoma Prevention | ||
| NCT01430572 | Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients | ||
| NCT01012401 | Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer | ||
| NCT02649764 | Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | ||
| NCT00501644 | Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | ||
| NCT02055963 | Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer | ||
| NCT01880645 | Selective Image Guided Resection of Axillary Lymph Nodes | ||
| NCT00726830 | Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer | ||
| NCT05673928 | A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB) | ||
| NCT01173692 | Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study. |
